Annual Drug Patent Expirations for QTERNMET+XR Qternmet Xr is a drug marketed by Astrazeneca Ab and is included in one […]
New patent expiration for Astrazeneca Ab drug QTERNMET XR Read Post »
Annual Drug Patent Expirations for ONGLYZA Onglyza is a drug marketed by Astrazeneca Ab and is included in one NDA.
New patent expiration for Astrazeneca Ab drug ONGLYZA Read Post »
Annual Drug Patent Expirations for QTERN Qtern is a drug marketed by Astrazeneca Ab and is included in two NDAs.
New patent expiration for Astrazeneca Ab drug QTERN Read Post »
Annual Drug Patent Expirations for KOMBIGLYZE+XR Kombiglyze Xr is a drug marketed by Astrazeneca Ab and is included in one
New patent expiration for Astrazeneca Ab drug KOMBIGLYZE XR Read Post »
Annual Drug Patent Expirations for BEPREVE Bepreve is a drug marketed by Bausch And Lomb Inc and is included in
New patent expiration for Bausch And drug BEPREVE Read Post »
Annual Drug Patent Expirations for DEXILANT+SOLUTAB Dexilant Solutab is a drug marketed by Takeda Pharms Usa and is included in
New patent expiration for Takeda Pharms drug DEXILANT SOLUTAB Read Post »
DEXILANT SOLUTAB (dexlansoprazole) Takeda pharms usa Patent: 6,664,276 Expiration: Jul 30, 2023 See More … For more information on how
Drug Patent Expirations for the Week of July 30, 2023 Read Post »
Annual Drug Patent Expirations for DEXILANT Dexilant is a drug marketed by Takeda Pharms Usa and is included in two
New patent expiration for Takeda Pharms drug DEXILANT Read Post »
Annual Drug Patent Expirations for SYMBICORT Symbicort is a drug marketed by Astrazeneca and is included in one NDA. It
New patent expiration for Astrazeneca drug SYMBICORT Read Post »
Get fresh news and insights, drug patent expirations & more…
